Synergistic Interaction of Telomerase-Specific Oncolytic Virotherapy and Chemotherapeutic Agents for Human Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|13|9|1809-1816

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.13, Iss.9, 2012-07, pp. : 1809-1816

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Telomerase-Specific Oncolytic Virotherapy for Human Cancer with the hTERT Promoter

By  

Current Cancer Drug Targets, Vol. 7, Iss. 2, 2007-03 ,pp. : 191-201

Bentham Science Publishers

Access to resources Recommend Favorite

Oncolytic Virotherapy for Breast Cancer Treatment

By  

Current Gene Therapy, Vol. 18, Iss. 4, 2018-08 ,pp. : 192-205

Bentham Science Publishers

Access to resources Recommend Favorite

Antiviral activity of cidofovir against telomerase-specific replication-selective oncolytic adenovirus, OBP-301 (Telomelysin)

By Ouchi Masaaki   Kawamura Hitoshi   Urata Yasuo   Fujiwara Toshiyoshi  

Investigational New Drugs, Vol. 27, Iss. 3, 2009-06 ,pp. : 241-245

Springer Publishing Company

Access to resources Recommend Favorite

Combining Oncolytic Virotherapy and Cytotoxic Therapies to Fight Cancer

By  

Current Pharmaceutical Design, Vol. 20, Iss. 42, 2014-12 ,pp. : 6513-6521

Bentham Science Publishers

Access to resources Recommend Favorite

Converting Viral Villains to Cancer Cures: Oncolytic Virotherapy Creeps Closer to the Clinic

By Adis International Limited  

Pharmaceutical & Diagnostic Innovation, Vol. 3, Iss. 11, 2005-01 ,pp. : 8-12

Adis International

Access to resources Recommend Favorite